CAR-Ts: New Perspectives in Cancer Therapy

Investigators address potential future targets to overcome the flaws of CAR-T cell technology in the treatment of cancer, emphasizing glycan antigens, the aberrant forms of which attain high tumour-specific expression, as alternative targets for CAR-T cells.